| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |